John D Reveille Selected Research

Ankylosing Spondylitis

12/2022	Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study.
9/2022	Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study.
8/2022	Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study.
4/2022	Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients.
1/2022	Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years.
1/2022	The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort.
10/2021	HLA-B27 is associated with reduced disease activity in axial spondyloarthritis.
4/2021	The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial.
1/2021	Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study.
11/2020	Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John D Reveille Research Topics

Disease

57	Ankylosing Spondylitis 12/2022 - 03/2003
30	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 08/2002
23	Systemic Scleroderma (Systemic Sclerosis) 11/2016 - 01/2003
14	Arthritis (Polyarthritis) 02/2016 - 04/2003
12	Inflammation (Inflammations) 08/2020 - 10/2004
10	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 07/2006
8	Back Pain (Backache) 08/2022 - 01/2009
8	Axial Spondyloarthritis 03/2022 - 06/2013
8	Disease Susceptibility (Diathesis) 01/2019 - 05/2005
7	Hypertension (High Blood Pressure) 01/2022 - 07/2006
7	Infections 02/2020 - 04/2003
6	Melanoma (Melanoma, Malignant) 01/2017 - 07/2002
6	Myositis (Idiopathic Inflammatory Myopathies) 08/2009 - 04/2003
5	Thrombosis (Thrombus) 07/2014 - 12/2004
4	Ankylosis 12/2022 - 03/2003
4	Sacroiliitis 01/2019 - 01/2011
4	Necrosis 01/2018 - 04/2003
4	Neoplasms (Cancer) 01/2016 - 05/2005
4	Lupus Nephritis 05/2014 - 06/2009
4	Pulmonary Hypertension 12/2009 - 10/2002
4	Connective Tissue Diseases (Connective Tissue Disease) 07/2009 - 10/2002
4	Polymyositis 11/2006 - 01/2003
3	Spondylitis 01/2019 - 06/2006
3	Pain (Aches) 01/2018 - 01/2009
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2016 - 01/2015
3	Genetic Predisposition to Disease (Genetic Predisposition) 12/2015 - 03/2011
3	Lymphopenia (Lymphocytopenia) 07/2015 - 10/2006
3	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2013 - 06/2006
3	Spondylarthropathies 04/2013 - 05/2007
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2012 - 10/2006
3	Psoriatic Arthritis 04/2012 - 03/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2009 - 04/2003
3	Dermatomyositis (Dermatopolymyositis) 08/2009 - 11/2005
3	HIV Infections (HIV Infection) 07/2009 - 04/2003
3	Osteonecrosis (Kienbock's Disease) 07/2009 - 07/2006
2	COVID-19 09/2022 - 01/2021
2	Genetic Risk Score 04/2022 - 03/2022
2	Osteoporosis 09/2020 - 05/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 01/2018
2	Iritis 02/2016 - 02/2016
2	Leukopenia 07/2015 - 10/2006
2	Hemolytic Anemia 07/2015 - 09/2008
2	Vasculitis (Vasculitides) 07/2015 - 07/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2013 - 07/2005
2	Rheumatoid Arthritis 06/2013 - 10/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2012 - 03/2011

Drug/Important Bio-Agent (IBA)

19	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2022 - 06/2006
14	AutoantibodiesIBA 10/2014 - 01/2003
12	AntibodiesIBA 02/2020 - 11/2004
10	C-Reactive ProteinIBA 09/2022 - 12/2008
9	CytokinesIBA 04/2015 - 07/2002
8	Biomarkers (Surrogate Marker)IBA 03/2022 - 07/2008
7	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 03/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2004
7	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 07/2002
6	golimumab FDA Link 12/2022 - 01/2018
6	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 06/2005
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2020 - 01/2009
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 07/2002
5	HLA-B Antigens (HLA-B)IBA 01/2019 - 01/2013
5	GlucocorticoidsIBA 02/2016 - 07/2005
5	InterferonsIBA 01/2013 - 02/2010
4	Immunoglobulin G (IgG)IBA 08/2020 - 07/2006
4	Peptides (Polypeptides)IBA 07/2013 - 11/2005
4	Antiphospholipid AntibodiesIBA 08/2012 - 12/2004
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2010 - 05/2005
3	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 08/2022 - 03/2013
3	HLA-A Antigens (HLA-A)IBA 01/2019 - 11/2005
3	HLA-C Antigens (HLA-C)IBA 01/2019 - 03/2011
3	Monoclonal AntibodiesIBA 02/2016 - 07/2006
3	Interleukin-23 (Interleukin 23)IBA 04/2015 - 12/2009
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 02/2010
3	Interferon Type IIBA 01/2014 - 01/2010
3	ametantrone (HAQ)IBA 04/2013 - 05/2007
3	AutoantigensIBA 04/2012 - 04/2008
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
3	Genetic Markers (Genetic Marker)IBA 02/2011 - 03/2003
3	EpitopesIBA 05/2010 - 05/2005
3	Azathioprine (Imuran)FDA LinkGeneric 09/2008 - 07/2006
3	anticentromere antibodyIBA 03/2007 - 01/2003
3	anti-scl-70 autoantibodiesIBA 02/2005 - 01/2003
2	ixekizumabIBA 01/2022 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 11/2020 - 05/2007
2	Pharmaceutical PreparationsIBA 11/2020 - 09/2020
2	Opioid Analgesics (Opioids)IBA 09/2020 - 01/2018
2	Biological ProductsIBA 09/2020 - 06/2013
2	micaIBA 01/2020 - 08/2014
2	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019 - 12/2009
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2016 - 01/2003
2	Interleukin-12 Subunit p40IBA 09/2015 - 04/2015
2	Antinuclear AntibodiesIBA 06/2015 - 08/2004
2	InterleukinsIBA 04/2015 - 02/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2014 - 11/2013
2	ChemokinesIBA 01/2014 - 01/2013
2	AminopeptidasesIBA 07/2013 - 07/2011

Therapy/Procedure

17	Therapeutics 01/2018 - 04/2003
4	Highly Active Antiretroviral Therapy (HAART) 07/2009 - 04/2003
3	Physical Therapy Modalities (Physical Therapy Technique) 02/2016 - 05/2012
2	Arthroplasty 02/2016 - 02/2016